Despite the recall, the FDA wants consumers to know Zantac is relatively safe
Over the last few months, there have been numerous U.S. Food and Drug Administration recalls due to carcinogen concerns in heartburn medications. We’ve written about each of them here at TFF, and even posted an article just a couple weeks ago providing consumers with what the FDA considers “safe alternatives”…
Amid Zantac drug recall, FDA identifies “safe” heartburn drug alternatives
The popular heartburn medication Zantac has been recalled by the company and the U.S. Food and Drug Administration over N-Nitrosodimethylamine (NDMA) concerns. The recall began in the United States, and has reached Canada, Asia, and Europe. Initially, even the generic alternatives to Zantac were thought to be tainted, but it…
Dr. Reddy’s heartburn drug recalled over NDMA concerns
Dr. Reddy’s has joined the growing list of companies issuing a recall of heartburn medications. This week, Dr. Reddy’s Laboratories Ltd. and the U.S. Food and Drug Administration announced a recall of their “ranitidine medicines used to treat heartburn” after they were found to contain the carcinogen N-Nitrosodimethylamine aka NDMA.
Multiple retailers pull Zantac from shelves amid carcinogen concerns
We wrote a couple of weeks ago about Valisure’s findings regarding the carcinogen Nitrosodimethylamine (NDMA) being found in Zantac and its generic forms. At the time, consumer advocacy groups were much more concerned with the report of a possibility of a carcinogen being found in a very common heartburn medication.…
Zantac and its generic versions contain carcinogen NDMA
While they have not been recalled, “possible carcinogens” have been detected in the heartburn drug Zantac, and its generic forms. Nitrosodimethylamine (NDMA) is the carcinogen detected by the U.S. Food and Drug Administration and European drug regulators.
An independent company named Valisure tested the drugs, and turned their findings over…